Lv1
40 积分 2024-11-17 加入
Timing of First Pembrolizumab Infusion and Long-Term Outcomes in Non-Small Cell Lung Cancer: A Retrospective Multicenter Study
10个月前
已完结
Timing of First Pembrolizumab Infusion and Long-Term Outcomes in Non-Small Cell Lung Cancer: A Retrospective Multicenter Study
10个月前
已完结
Rechallenge with immune-checkpoint inhibitors in patients with advanced-stage lung cancer
11个月前
已完结
Early morning immune checkpoint blockade and overall survival of patients with metastatic cancer: An In-depth chronotherapeutic study
1年前
已完结
Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
1年前
已完结
皖公网安备34019202002308
